XML 48 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Company’s stock plans and related information:
(In thousands, except exercise prices and years)Options
Outstanding
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining Contract
Life (in years)
Aggregate
Intrinsic Value (a)
Balance at December 31, 202219,320 $3.38 8.0$29 
Granted6,179 1.05 
Exercised(1)1.29 
Canceled/forfeited(2,470)2.46 
Balance at December 31, 202323,028 $4.87 7.2$99 
Vested and expected to vest as of December 31, 202323,028 $4.87 7.2$99 
Exercisable at December 31, 202310,352 $8.42 5.9$48 
(a)The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company’s common stock as quoted on a national exchange.
Schedule of Fair Value of Option Issued Valuation Assumptions
The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:
OptionsEmployee Stock Purchase Plan
Years ended December 31,Years ended December 31,
2023202220232022
Expected volatility90%89%78%77%
Expected term (in years)6.06.01.31.2
Expected dividend yield
Risk-free interest rate4.2%2.6%5.0%3.0%
Schedule of Restricted Stock Units Activity
The following table summarizes the RSU activity under the Company’s stock plans and related information:
(In thousands, except grant date fair value and years)Number of
Units
Weighted-
Average
Grant Date
Fair Value
Weighted-
Average
Remaining
Contractual Term
(in years)
Balance at December 31, 20221,693 2.90 1.2
Granted560 0.77 
Vested and released(491)3.14 
Forfeited(219)2.07 
Balance at December 31, 20231,543 $2.17 1.4
Schedule of Stock-based Compensation Expense
The following table presents the Company’s stock-based compensation expense:
Years ended December 31,
20232022
(In thousands)
Research and development$4,969 $7,108 
General and administrative12,600 12,971 
Total share-based compensation expense$17,569 $20,079